Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06234228 · ClinicalTrials.gov registry record · NA
Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures
A NA study of Pain and Anxiety, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
- 1
- Study location
NCT06234228: Active NA study of Pain and Anxiety, sponsored by Stanford University.
NCT06234228 is a NA study of Pain and Anxiety that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 1,100 participants, above the 301-participant average among 374 other Pain trials with a reported enrollment target (265% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06234228, a NA study of Pain and Anxiety, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
This pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.
Primary Outcome
OBSD-r contains 8-item scale assessing participant's affective state; Information Seeking, Crying, Screaming, Restraint, Verbal Resistance, Emotional Support, Verbal Pain and Flail.
Interventions
- BEHAVIORAL Bluetooth Haptic Device (BHD)
- BEHAVIORAL BHD synced with mobile game
Study Locations (1)
California
- Lucile Packard Childrens Hospital Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2026-11-04 |
| Phase | NA |
What the registry record for NCT06234228 still lists
NCT06234228 is an interventional study that assigns participants to a tested intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, above the 301-participant average among 374 other Pain trials with a reported enrollment target (265% higher).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Bluetooth Haptic Device (BHD) is the first listed.
NCT06234228 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06234228 about?
NCT06234228 is a clinical study titled "Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures". This pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.
What is the current status of trial NCT06234228?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,100 participants. The study started on 2024-07-25. Estimated completion is 2026-11-04.
What conditions does trial NCT06234228 study?
This clinical trial studies the following conditions: Pain, Anxiety.
What interventions are being tested in trial NCT06234228?
The interventions under investigation include: Bluetooth Haptic Device (BHD) (BEHAVIORAL), BHD synced with mobile game (BEHAVIORAL).
Who is sponsoring clinical trial NCT06234228?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06234228 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06234228's enrollment target sits among peer trials
1,100 11th of 374 higher than 364 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI